WASHINGTON — A new kind of flu vaccine moved a step closer to the U.S. market Thursday as federal health advisers recommended approval of the first made with the same mRNA technology that was key to ending the COVID-19 pandemic.The Food and Drug Administration is evaluating Moderna’s new shot, d...
Liking and disliking news Highlights will help Daily News Highlights to understand visitor interests and top trends as per the user behavior hence this feature requires visitor to Sign In, if you are not registered yet, please Sing Up to personalize your reading.